Safety and Tolerability of Lenalidomide Maintenance in Post-Transplant Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Investigators conducted a single-center Phase I dose-escalation study with lenalidomide maintenance in high-risk myelodysplastic syndrome and acute myeloid leukemia patients after allogeneic transplantation.